Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| George Harrum | M | - | 23 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| George Raymond Jensen | M | 75 | 19 years | |
| Steven Katz | M | 76 |
Gammacan International, Inc.
 Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | 11 years |
| Limor Zur-Stoller | F | 55 |
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | - |
| Denis Kouznetsov | M | - | 16 years | |
| Bradley Tirpak | M | 54 | 4 years | |
| Jack Edward Price | M | 78 | - | |
| William J. Reilly | M | 76 | 8 years | |
| Frank A. Petito | M | 56 | 2 years | |
| Steve G. Illes | M | - | - | |
| Albert Passner | M | - |
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | 2 years |
| Deborah G. Arnold | F | 73 | 3 years | |
| William J. Schoch | M | 59 | 8 years | |
| Joel P. Brooks | M | 65 | 13 years | |
| Maeve McKenna Duska | F | 49 | 16 years | |
| Bruce R. Shirey | M | - | - | |
| Cary M. Sagady | M | - | - | |
| Veronica Rosa | F | - | - | |
| Mary West Young | F | 68 | - | |
| Stephen W. McHugh | M | 66 | 3 years | |
| Chaime Orlev | M | 53 |
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | 3 years |
| John McLaughlin | M | - | 5 years | |
| James D. Smith | M | 65 | 1 years | |
| Peter A. Michel | M | 81 | 1 years | |
| Yair Aloni | M | 74 |
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | - |
| Shmuel Levi | M | - |
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | - |
| William L. van Alen | M | 89 | 17 years | |
| Scott Nissenbaum | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 24 | 85.71% |
| Israel | 6 | 21.43% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David M. DeMedio
- Personal Network
